摘要:
The present invention relates to novel 4-substituted quinoline compounds of the following formula, libraries containing such compounds, and to the generation of such combinatorial libraries composed of such compounds: wherein R1, R2, R3, R4, R5, R6, R7, R9, and Y, have the meanings provided.
摘要:
The present invention relates to novel 4-substituted quinoline compounds of the following formula, libraries containing such compounds, and to the generation of such combinatorial libraries composed of such compounds: wherein R1, R2, R3, R4, R5, R6, R7, R9, and Y, have the meanings provided.
摘要:
The present invention relates to novel tricyclic tetrahydroquinoline compounds of the following formula, libraries containing such compounds, and to the generation of such combinatorial libraries composed of such compounds: ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, n, and Y have the meanings provided.
摘要:
A room temperature stable and minimal aggregate liquid formulation comprises an oligonucleotide comprising Seq ID No. 1: or comprising a variant oligonucleotide in which no more than 3 non-sequential bases are different from Seq. ID NO. 1 and an aqueous carrier comprising a aggregation-preventing compound selected from the group consisting of mono and disaccharides and/or sugar alcohols.
摘要翻译:室温稳定和最小的骨液制剂包含含有Seq ID No.1的寡核苷酸,或包含其中不超过3个非顺序碱基不同于Seq的变体寡核苷酸。 证件号码。 1和包含选自单糖和二糖和/或糖醇的聚集体防止化合物的水性载体。
摘要:
A room temperature stable and minimal aggregate liquid formulation comprises an oligonucleotide comprising Seq ID No. 1: or comprising a variant oligonucleotide in which no more than 3 non-sequential bases are different from Seq. ID NO. 1 and an aqueous carrier comprising a aggregation-preventing compound selected from the group consisting of mono and disaccharides and/or sugar alcohols.
摘要翻译:室温稳定和最小的骨液制剂包含含有Seq ID No.1的寡核苷酸,或包含其中不超过3个非顺序碱基不同于Seq的变体寡核苷酸。 证件号码。 1和包含选自单糖和二糖和/或糖醇的聚集体防止化合物的水性载体。